GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
161.08
+14.53 (9.91%)
At close: Nov 24, 2025, 4:00 PM EST
159.50
-1.58 (-0.98%)
After-hours: Nov 24, 2025, 7:10 PM EST
GeneDx Holdings Market Cap
GeneDx Holdings has a market cap or net worth of $4.66 billion as of November 24, 2025. Its market cap has increased by 123.15% in one year.
Market Cap
4.66B
Enterprise Value
4.62B
1-Year Change
123.15%
Ranking
Category
Stock Price
$161.08
Market Cap Chart
Since November 4, 2020, GeneDx Holdings's market cap has decreased from $17.90B to $4.66B, a decrease of -73.99%. That is a compound annual growth rate of -23.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 4.24B | 100.62% |
| Dec 31, 2024 | 2.11B | 2,866.28% |
| Dec 29, 2023 | 71.18M | -30.24% |
| Dec 30, 2022 | 102.04M | -90.52% |
| Dec 31, 2021 | 1.08B | -94.66% |
| Dec 31, 2020 | 20.16B | 12.65% |
| Nov 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 948.84B |
| Johnson & Johnson | 491.26B |
| AbbVie | 417.60B |
| UnitedHealth Group | 289.84B |
| AstraZeneca | 280.49B |
| Novartis AG | 243.93B |
| Merck & Co. | 242.64B |
| Abbott Laboratories | 222.77B |